FRANK CASELLA: Open Payments
NPI 1306888912 · SPARTA, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$227 in 13 payments from 3 companies in 2025. Trend: 2023 $54 · 2024 $81 · 2025 $227
Food & beverage: $227
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $189 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
Products named: Wegovy, Rybelsus, Ozempic, TRELEGY ELLIPTA, ZORYVE.
Industry payments across NJ — which companies pay providers there.
